Literature DB >> 9862696

Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.

N Eiraku1, R Hingorani, S Ijichi, K Machigashira, P K Gregersen, J Monteiro, K Usuku, S Yashiki, S Sonoda, M Osame, W W Hall.   

Abstract

To investigate the diversity of the T cell repertoire involved in human T lymphotropic virus type I (HTLV-I) infections, peripheral blood T cell subsets were analyzed by using a PCR-based assay that permits determination of complementarity-determining region 3 (CDR3) length variation in TCR Vbeta transcripts. In two of four asymptomatic HTLV-I carriers and in four of five patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligoclonal expansions were detected in the CD4+ T cell subset. In one patient with adult T cell leukemia, a specific clone bearing Vbeta7 was detected in the CD4+ T cell subset. In contrast, clonal expansion was not observed in the CD4 T cell subsets of three individuals with asymptomatic HTLV-II infection or in our previous studies of a large number of uninfected individuals. Oligoclonal expansions in the CD8+ T cell subset were detected in all subjects, including the patient with adult T cell leukemia. No differences in the number of expanded clones were noted between asymptomatic carriers and in patients with HAM/TSP and there was no obvious restriction in the TCR V region usage. Direct sequencing revealed no significant bias in the CDR3 motifs utilized by the predominant clones. This report is the first direct demonstration of clonal expansions within fractionated T cell subsets (CD4+ and CD8+) in HTLV-I infections and suggests that 1) clonal expansion of CD4+ T lymphocytes likely occurs as a direct result of infection and 2) polyclonal CD8+ T cell expansion occurs frequently and independently of disease association.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862696

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

2.  Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.

Authors:  Hirohisa Nose; Mineki Saito; Koichiro Usuku; Amir H Sabouri; Toshio Matsuzaki; Ryuji Kubota; Nobutaka Eiraku; Yoshitaka Furukawa; Shuji Izumo; Kimiyoshi Arimura; Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

3.  Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure.

Authors:  K D Bourcier; D G Lim; Y H Ding; K J Smith; K Wucherpfennig; D A Hafler
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.

Authors:  Yosuke Maeda; Hiromi Terasawa; Yuetsu Tanaka; Chisho Mitsuura; Kaori Nakashima; Keisuke Yusa; Shinji Harada
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

5.  In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes.

Authors:  M Saito; G P Taylor; A Saito; Y Furukawa; K Usuku; J N Weber; M Osame; C R Bangham
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.

Authors:  Zachary Klase; Kuan-Teh Jeang
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

Review 7.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.

Authors:  Toshiki Watanabe
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

8.  Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications.

Authors:  M Di Ianni; B Del Papa; D Cecchini; E Bonifacio; L Moretti; T Zei; R Iacucci Ostini; F Falzetti; L Fontana; G Tagliapietra; C Maldini; M F Martelli; A Tabilio
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

9.  High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets.

Authors:  Chunlin Wang; Catherine M Sanders; Qunying Yang; Harry W Schroeder; Elijah Wang; Farbod Babrzadeh; Baback Gharizadeh; Richard M Myers; James R Hudson; Ronald W Davis; Jian Han
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

10.  Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.

Authors:  Hirohisa Nose; Ryuji Kubota; Nilufer P Seth; Peter K Goon; Yuetsu Tanaka; Shuji Izumo; Koichiro Usuku; Yoshiro Ohara; Kai W Wucherpfennig; Charles R M Bangham; Mitsuhiro Osame; Mineki Saito
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.